PALM BEACH, Florida, December 15, 2016 /PRNewswire/ --
New legal marijuana markets and opportunities within the US cannabis industry are spurring development of new products and services as well as fueling the acquisition of land and other resources to capitalize on early momentum and cultivate efficiently heading into the new year. Today's Cannabis / Legal Marijuana companies in focus include: Arcturus Growthstar Technologies Inc. (OTC: AGSTF), American Cannabis Company, Inc. (OTC: AMMJ), Medical Marijuana, Inc. (OTC: MJNA), Terra Tech Corp. (OTC: TRTC) and GB Sciences, Inc. (OTC: GBLX).
Arcturus Growthstar Technologies Inc. (OTCQB: AGSTF)(CSE: AGS.CN) is pleased to announce that it has signed a Definitive Agreement ("the Contract") to acquire a 15-acre parcel of land in Redland, Florida, in a county that is designated to legally cultivate, process and dispense cannabis . Redland is an unincorporated community within Miami-Dade County, with Biscayne National Park to the east and Everglades National Park to the west. Redland is a Miami suburb and a major agricultural area. Miami-Dade County is referred to as the nation's "Salad Bowl" and "Winter Bread Basket." Read this and more news for Arcturus Growthstar at http://www.marketnewsupdates.com/news/agstf.html
"We are pleased to have reached this Contract to acquire this prime parcel of land as it has a long history as a plant nursery, which was first established in 1963," says Mr. William Gildea, Arcturus Growthstar Technologies Inc.'s CEO and Chairman. "Florida's Legislature is beginning the process of figuring out how to implement Amendment 2, which expands the legalization of medical marijuana in Florida by allowing higher-strength marijuana to be used for a wider list of medical ailments. With this 15-acre acquisition, Arcturus is positioning itself to be a part of Florida's cannabis market as it rolls out in 2017."
With this acquisition and the previously announced 10-acre greenhouse acquisition near Orlando, Arcturus has the potential, if fully licensed, to develop 25-acres of cannabis crops. If current state projections for the cannabis market size hold up to their $1.8B projection by 2020, Florida will have considerable demand for medical marijuana, even without factoring in the potential for recreational legislation. This is an exciting acquisition for Arcturus as the 15-acre farm is located in a designated legal grow zone with close proximity to Miami. Arcturus and its experienced team of operators, including John Sweeney, former VP of Operations for Tilray's 60,000-square foot Vancouver facility, is in a unique position as a Canadian based company because it is poised to quickly commence operations within the United States rather than potentially wait years to become a licensed producer under Canadian law.
In performances from yesterdays market activity and recent developments of note:
American Cannabis Company, Inc. (OTCQB: AMMJ) closed up over 3% on Wednesday at $0.8177 trading over 550,000 shares by the market close. American Cannabis Company, Inc., together with its subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting, provides solutions for businesses operating in the cannabis industry in the United States and Canada.
Medical Marijuana, Inc. (OTC PINK: MJNA) closed up over 9% on Wednesday at $0.1325 trading over 39 Million shares by the market close. Medical Marijuana, the first-ever publicly traded cannabis company in the United States, announced this week that it commends the Mexican senate for voting in favor of extending regulations for certain cannabis products. With the new regulations, more people in need of cannabis and cannabidiol (CBD) for medical care will have more access to products, including our RSHO brand of products.
Terra Tech Corp. (OTCQX: TRTC) closed down slightly on Wednesday at $0.268 trading over 4.5 Million shares by the market close. Terra Tech Corp., through its subsidiaries, engages in the design, marketing, and sale of hydroponic equipment with proprietary technology to create sustainable solutions for the cultivation of indoor agriculture in Newport Beach and Irvine,
GB Sciences, Inc. (OTCQB: GBLX) closed up over 3% at $0.305 on Wednesday trading over 440,000 shares by the market close. GB Sciences announced this week that its wholly-owned subsidiary, Growblox Life Sciences, LLC has licensed intellectual property from Makai Biotechnology, LLC. The patent underlying the license was issued by the USPTO in July of 2015, and claims therapeutic methods for the treatment of cardiac hypertrophy and associated pathologies through regulation of the cannabinoid receptor, TRPV1. TRPV1 can be regulated therapeutically by plant-based cannabinoids, which creates a plethora of potentially new therapeutic agents for the treatment of cardiac hypertrophy and heart failure.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Arcturus Growthstar Technologies Inc. by the company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Media Contact email: